ReviewFrontiers in aging neuroscience2021

Challenges and Limitations of Targeting the Keap1-Nrf2 Pathway for Neurotherapeutics: Bach1 De-Repression to the Rescue.

Dmitry M Hushpulian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.